Marshall Wace, LLP Rallybio Corp Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Rallybio Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 29,032 shares of RLYB stock, worth $38,902. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,032
Previous 15,025
93.22%
Holding current value
$38,902
Previous $35,000
51.43%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RLYB
# of Institutions
64Shares Held
30.7MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$5.62 Million0.03% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$4.87 Million2.37% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$4.42 Million5.35% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$4.06 Million0.12% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA2.4MShares$3.22 Million3.26% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $43.1M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...